TrialAnnals of the rheumatic diseases2005

Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial.

C Antoni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.